AbbVie : ABBV

All AbbVie Articles

622 Articles

Lee Jackson | Jun 1, 2018 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Dana, Humana, International Paper, Navistar, Southwest Airlines, Tesla and More

The top analyst upgrades, downgrades and other research calls from Friday include AbbVie, Dana, Humana, International Paper, Navistar, Southwest Airlines…

Lee Jackson | May 30, 2018 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Broadcom, Exxon, Fabrinet, HP, Match, Target and More

The top analyst upgrades, downgrades and other research calls from Wednesday include AbbVie, Apple, Broadcom, Exxon Mobil, Fabrinet, HP, Match…

Chris Lange | May 25, 2018 at 9:35 AM EDT

Major Pharma Short Sellers Grow More Selective

The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | May 10, 2018 at 10:20 AM EDT

Short Sellers Run for Cover From Major Pharma

The April 30 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | May 1, 2018 at 10:50 AM EDT

Why One Old Stock Buyback Trick Is Working So Well for AbbVie

AbbVie is trying one of the older and less-used efforts to drive its share price back up: a modified Dutch…

Chris Lange | Apr 25, 2018 at 8:35 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Apr 22, 2018 at 10:15 AM EDT

Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week

24/7 Wall St. has put together a preview of AbbVie, Eli Lilly and some of the other top pharma and…

Jon C. Ogg | Apr 17, 2018 at 11:35 AM EDT

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Rheumatoid arthritis is an autoimmune disease that attacks tissues within the joints, and it is a major target of U.S.…

Chris Lange | Apr 11, 2018 at 8:30 AM EDT

The Major Pharma Stocks That Are Making Short Sellers Sick

The March 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Mar 27, 2018 at 8:45 AM EDT

Which Major Pharma Stocks Short Sellers Are Keen On

The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Mar 26, 2018 at 4:08 PM EDT

Monday’s Biggest Winners and Losers in the S&P 500

Monday was an incredible day for the broad U.S. markets, with the Dow posting one of its top 3 performances,…

Chris Lange | Mar 24, 2018 at 8:25 AM EDT

How Analysts See AbbVie After the Big Disappointment

AbbVie shares took a big step back last week after the firm reported less than favorable results for its relapsed/refractory…

Jon C. Ogg | Mar 23, 2018 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, American Water, Carnival, Cisco, Darden, DexCom, Micron, Nike, Occidental Petroleum and More

The top analyst upgrades, downgrades and other research calls from Friday include AbbVie, American Water, Carnival, Cisco, Darden, DexCom, Micron…

Chris Lange | Mar 22, 2018 at 4:08 PM EDT

Thursday’s Biggest Winners and Losers in the S&P 500

Thursday was an absolute disaster for the broad U.S. markets. There didn’t seem to be anything positive about Thursday for…

Chris Lange | Mar 22, 2018 at 11:50 AM EDT

AbbVie Slides on Weak Midstage Results

AbbVie saw its shares pull back on Thursday after it reported less than favorable midstage results for its relapsed/refractory small…

1 … 22 23 24 25 26 … 42

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: AbbVie, Dana, Humana, International Paper, Navistar, Southwest Airlines, Tesla and More

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Broadcom, Exxon, Fabrinet, HP, Match, Target and More

Major Pharma Short Sellers Grow More Selective

Short Sellers Run for Cover From Major Pharma

Why One Old Stock Buyback Trick Is Working So Well for AbbVie

Short Sellers Grow More Selective on Major Pharma Stocks

Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

The Major Pharma Stocks That Are Making Short Sellers Sick

Which Major Pharma Stocks Short Sellers Are Keen On

Monday’s Biggest Winners and Losers in the S&P 500

How Analysts See AbbVie After the Big Disappointment

Top Analyst Upgrades and Downgrades: AbbVie, American Water, Carnival, Cisco, Darden, DexCom, Micron, Nike, Occidental Petroleum and More

Thursday’s Biggest Winners and Losers in the S&P 500

AbbVie Slides on Weak Midstage Results

Forget VFIAX: Vanguard Sells You the Same S&P 500 Fund Without the $3,000 Toll, or the $75 Fee Fidelity Charges to Buy It

Nvidia and Micron Have Driven the S&P 500’s 2026 Rally to Record Highs. History Says It’s Not Over

A Retired Couple Can Pull About $47,500 From Their IRAs This Year and Pay $0 Federal Tax. Most Leave the Free Space Unused.

A Retired Couple Can Pull About $47,500 From Their IRAs This Year and Pay $0 Federal Tax. Most Leave the Free Space Unused.

Social Security Said He Owed $18,000. Before Draining His Savings, He Had Three Cards to Play.

Forget VFIAX: Vanguard Sells You the Same S&P 500 Fund Without the $3,000 Toll, or the $75 Fee Fidelity Charges to Buy It

Nvidia and Micron Have Driven the S&P 500’s 2026 Rally to Record Highs. History Says It’s Not Over

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: AbbVie, Dana, Humana, International Paper, Navistar, Southwest Airlines, Tesla and More

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Broadcom, Exxon, Fabrinet, HP, Match, Target and More

Major Pharma Short Sellers Grow More Selective

Short Sellers Run for Cover From Major Pharma

Why One Old Stock Buyback Trick Is Working So Well for AbbVie

Short Sellers Grow More Selective on Major Pharma Stocks

Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

The Major Pharma Stocks That Are Making Short Sellers Sick

Which Major Pharma Stocks Short Sellers Are Keen On

Monday’s Biggest Winners and Losers in the S&P 500

How Analysts See AbbVie After the Big Disappointment

Top Analyst Upgrades and Downgrades: AbbVie, American Water, Carnival, Cisco, Darden, DexCom, Micron, Nike, Occidental Petroleum and More

Thursday’s Biggest Winners and Losers in the S&P 500

AbbVie Slides on Weak Midstage Results

Forget VFIAX: Vanguard Sells You the Same S&P 500 Fund Without the $3,000 Toll, or the $75 Fee Fidelity Charges to Buy It

Nvidia and Micron Have Driven the S&P 500’s 2026 Rally to Record Highs. History Says It’s Not Over

A Retired Couple Can Pull About $47,500 From Their IRAs This Year and Pay $0 Federal Tax. Most Leave the Free Space Unused.

Featured Reads

A Retired Couple Can Pull About $47,500 From Their IRAs This Year and Pay $0 Federal Tax. Most Leave the Free Space Unused.

Social Security Said He Owed $18,000. Before Draining His Savings, He Had Three Cards to Play.